MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CTOR made $1,667,298 in revenue. -$26,609,695 in net income. Net profit margin of -1595.98%.

Income Overview

Revenue
$1,667,298
Net Income
-$26,609,695
Net Profit Margin
-1595.98%
EPS
-$0.27
Unit: Dollar
Revenue Breakdown
    • Gross product revenue
    • Gross-to-net adjustments

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
1,667,298 3,944,111 -0
Cost of revenues
328,878 789,208 --
Gross profit
1,338,420 3,154,903 --
Research and development
1,079,354 1,018,352 1,076,136 938,277
Amortization of in-process research and development
1,720,312 573,438 --
Revenues
---0
General and administrative
23,625,639 2,859,339 1,337,244 1,881,447
Stock-based compensation general and administrative
3,526,710 3,956,050 2,298,132 2,125,237
Total operating expenses
29,952,015 8,407,179 4,711,512 4,944,961
Operating loss
-28,613,595 -5,252,276 -4,687,001.25* -4,944,961
Interest income
43,721 28,288 9,093.25* -
Gain on sale of new jersey net operating losses
1,762,000 ---
Interest expense
33,031 45,841 54,508* 160,755
Total other income, net
1,772,690 -17,553 -45,414.75* -
Loss before income taxes
-26,840,905 -5,269,829 -4,732,416 -5,105,716
Income tax expense (benefit)
-231,210 264,240 264,240 264,240
Net loss
-26,609,695 -5,534,069 -4,996,656 -5,369,956
Basic EPS
-0.27 -0.06 -0.064 -0.08
Diluted EPS
-0.27 -0.06 -0.064 -0.08
Basic Average Shares
100,027,204 87,462,385 78,414,670 71,552,402
Diluted Average Shares
100,027,204 87,462,385 78,414,670 71,552,402
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$26,609,695 (-243.99%↓ Y/Y)Income tax expense(benefit)-$231,210 (-187.50%↓ Y/Y)Gain on sale of newjersey net operating...$1,762,000 Interest income$43,721 Gross product revenue$2,003,760 Loss before incometaxes-$26,840,905 (-259.25%↓ Y/Y)Total other income,net$1,772,690 Revenues$1,667,298 Interest expense$33,031 Gross-to-net adjustments$336,462 Operating loss-$28,613,595 Gross profit$1,338,420 Cost of revenues$328,878 Total operatingexpenses$29,952,015 (300.89%↑ Y/Y)General andadministrative$23,625,639 (953.15%↑ Y/Y)Stock-based compensation general and...$3,526,710 (68.86%↑ Y/Y)Amortization of in-processresearch and development$1,720,312 Research and development$1,079,354 (-65.62%↓ Y/Y)

CITIUS ONCOLOGY, INC. (CTOR)

CITIUS ONCOLOGY, INC. (CTOR)